BCL2 and cancer: Overexpressed BCL2 is associated with aberrant carcinoma growth in various human diseases, particularly with solid tumors, such as lymphomas, non-small-cell lung cancer, myeloma, and melanoma, having been recognized as targets for cancer therapy in the past three decades [117].